Post-translational protein modifications have contributed significantly to the identification of macromolecular biomarkers of biological processes. We have modified a two-dimensional HPLC system (Beckman Coulter PF2D ProteomeLab) to create proteome maps of post-translational protein modifications. This system resolves complex protein mixtures by anion exchange chromatofocusing in the first dimension and hydrophobicity (reverse phase chromatography) in the second dimension. The simultaneous identification of multiple protein modifications, accomplished by incorporating a photo diode array (PDA) detector into the PF2D system, facilitates the simultaneous production of threedimensional proteome maps and visualization of both unmodified and post-translationally modified (PTM) proteins at their signature wavelengths within the proteome. We describe procedures for the simultaneous resolution of proteome maps, the identification of proteins modified by nitration, carbonylation, and phosphorylation, and proteins with unique spectra such as the heme containing proteins.
Introduction
Recent advances in identification of multiple posttranslational modifications have proven to be important markers of normal and pathological biological processes. 1 This rapid increase of biomarker identification encompasses such pathological circumstances as cancer, 2 cardiovascular disease, 3 brain injury, 4 trauma 5 and population proteomics 6 as well as normal biological processes of development. 7 The ability to apply high-throughput proteomics technologies to the simultaneous and global detection of post-translationally modified proteins or changes in protein pool levels augments the development of biomarker proteome maps for specific biological processes.
Standard methods of visualization of proteome maps involving the classical two-dimensional gel electrophoresis coupled with immunoblotting analysis and mass spectrometry are commonly used for biomarker identification within proteome maps of specific tissues, for example, cardiac tissue, 8 liver 9 and organelles. [10] [11] [12] However, this procedure has disadvantages such as limited detection of proteins with extreme hydrophobicity, mass or isoelectric point, as well as sample recovery and reproducibility of patterns. 13, 14 Through the use of the PF2D system, we have overcome many of these problems. Unlike 2-DE, the PF2D system is highly reproducible and provides such advantages as the ability to archive the fractions for later analysis and analyze fractions by direct application to various mass spectrometry technologies and/or Western blotting. Furthermore, the collection times can be altered or fractions can be reinjected for expanded resolution of protein mixtures.
The uniqueness of our system is its ability to simultaneously develop multiple proteome maps of specific biomarkers, thus, providing basic information on the character of biological processes associated with normal and pathological conditions. With the rapid development of protein modification chemistry, our system facilitates the detection of many known PTMs involved in these biological processes and allows us to analyze the mechanisms for the production of such PTMs.
Materials and Methods
Modification of the PF2D Fractionation System. To facilitate the construction of multiple proteome maps, we modified the PF2D by incorporating a photo diode (PDA) array (Beckman Coulter 168 Photo Diode Array) into the system to compliment the tunable single wavelength detectors used for the generation of the first-and second-dimensional fractionation tracings ( Figure 1) . The PDA has an additional two tunable single wavelength channels and a capability that scans absorbance from 190 to 600 nm/s. Thus, we have a system with a tunable channel in the first dimension and three tunable channels and a scanner in the second dimension. Together, these generate 3D and contour proteome maps using the 32 Karat software (Beckman Coulter) and monitors up to three wavelengths for unmodified and modified proteins. Incorporation of the PDA has facilitated the detection of PTMs that are either derivitizations of a particular adduct that generates a unique absorbance (e.g., the diphenylhydrazine derivitization of carbonyls that generates a diphenylhydrazone adduct having an absorbance at ∼350 nm (acidic) and derivatized phosphoproteins, i.e., using Pro-Q Diamond LC Phospho Peptide Detection Kit (Invitrogen) at 550-580 nm); or directly by detecting a PTM with distinctive absorbance (e.g., nitrated proteins at 360 nm). Fractions are collected in the first dimension from pH 8.5-4.0 at 0.3 pH intervals or 1 mL. These fractions are separated in the second dimension by hydrophobicity (nonporous reverse phase) typically 18 1-min intervals from 6-23 min. UV data are collected from a 100% aqueous phase to a 100% organic phase over 35 min.
Incorporating a Photodiode Array Detector Model 168 (Beckman Coulter) into a PF2D System. Plumbing. The 168 was plumbed following the second dimension 166 detector by disconnecting the outlet line going to the Gilson fraction collector and connecting it to the inlet line of the 168. The outlet line from the 168 was then connected to the fraction collector.
Communication: A remote I/O cable is modified by removing one end and isolating two wires; the brown with white tracer, and the solid red wire. These correspond to pins 15 and 16, respectively. These two wires are connected to the remote interface unit of the PF2D at terminals 15 Table 50 or so entries that can be edited following the creation of the sequence table from the PF2D. It is highly recommended Figure 1 . A schematic diagram of the modified protein fractionation system with PDA. Proteins are injected into the first dimension chromatofocusing column, monitored by the UV detector at 280 nm, and collected into a 96 well plate at 0.3 pH or 1 mL intervals. These fractions are injected into the second dimension reverse phase column by the fraction collector/injector for further separation, monitored by a second UV detector at 214 nm, and scanned by a PDA from 190 to 600 nm. The PDA also supports two single channel tunable wavelengths for PTM with unique wavelengths. The protein fractions are finally collected into an eight plate fraction collector for archive or for further analysis including robot printing of arrayed fractions for Western analysis.
that "date and time" be selected as one of the values for the data file since data files cannot have the same names.
Preparation of Protein Samples for PF2D Fractionation. DNP-Derivatized Serum Albumin. Carbonylation of commercially available serum albumin was carried out according to the method of Levine et al. 15 The derivatized albumin was prepared in water before injecting into the second dimension reverse phase columnm.
Nitrotyrosine Modified Proteins. Nitrated bovine serum albumin (BSA) was purchased from Cayman Chemicals, Ann Arbor, MI (catalog No. 89542). Nitrated lysozyme was prepared by the method of Bian et al. 16 Both BSA and lysozyme were prepared in start buffer before injecting them into the PF2D system.
Proteins with Unique Spectra. Cytochrome c was purchased from MP Biomedicals. Myoglobin was purchased from Sigma. Both cytochrome c and myoglobin were prepared in water before injecting into the second dimension reverse phase column.
Phosphorylated Proteins. To view phosphorylated proteins, we employed a fluorescence based detection system (Molecular Probes, Pro-Q Diamond LC). The phosphopeptide detection system is specifically for HPLC separation and UV detection of phosphopeptides (excitation/emission maxima 555/580). The system is designed to detect phosphothreonine, phosphotyrosine, and phosphoserine containing peptides at slightly altered retention times. In addition to the detection of phosphopeptides, we have employed the system for the detection of phosphoproteins, and to survey phosphoproteins in a proteome (liver) using an altered protocol. Briefly, proteins in PF2D start buffer were desalted using Zeba Desalt Spin Columns (Pierce) after adding 50% ethanol to 20% of the total volume. All reagents were 10-fold higher than protocol recommendations, that is, 25 µL of Pro-Q Diamond detection reagent and 25 µL of 10× activation reagent were added to 200 µL sample from Zeba spin column for a total volume of 250 µL. Membrane lysis buffer (50 µL) was then added to resuspend ppt proteins. Desalted Pro-Q labeled sample (100-200 µL) was then injected into the second dimension of the PF 2D/ PDA system.
Isolation of Liver Proteins. Snap-frozen liver samples were thawed and homogenized in membrane lysis buffer (5 M urea, 
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DeFord et al. 20 in/Hg until the wells cleared. The wells were then washed a second time with 200 µL of TB followed by vacuum and the membranes removed to transfer buffer for blocking or dried for extended storage (soak in 100% methanol then placed on blotting paper until dry) at -20°C. Sample volumes vary, but typically, 10 µL of first-dimension sample and 100 µL of seconddimension sample were applied for Western analysis. Membranes were blocked with blocking solution containing 5% nonfat dry milk in TBS-T (50 mM Tris-HCl, pH 7.4, 20 mM NaCl, 0.05% (v/v) Tween-20) for 1 h. Primary antibody diluted in blocking solution was added to the membranes for varying times according to recommendations by the manufacturer of the antibody. The membranes were washed three times for 5 min each in TBS-T. The HRP conjugated-secondary antibody diluted in blocking solution was added for 1 h followed by washing in TBS-T for 15 min and twice additionally for 5 min each. Membranes were incubated by either Pierce SuperSignal West Pico chemiluminescent substrate or Millipore Western HRP substrate for 5 min and immunoreactive spots were visualized by exposing the membrane to Kodak X-OMAT film for appropriate times. If needed, membranes were stripped with Restore Western Blot Stripping Buffer (Pierce) for 5-15 min and reprobed with other antibodies as described above.
Results

Modification of the PF2D Spectrophotometric Detection
System. To expand the capabilities to simultaneously develop multiple proteome maps, we modified the PF2D by adding a Photo Diode Array (PDA) to the system to complement the tunable single wavelength of the PF2D detectors already incorporated into the first and second dimensions of the system. The PDA-168 (Beckman Coulter) has two tunable single wavelength channels and a scanning capability that includes absorbance from 190 to 600 nm (Figure 1 ). The goal of this additional capability is to detect PTMs that result in new absorbance characteristics in addition to their signature absorbance at 214/280 nm.
Detection of Carbonylated Proteins. Carbonyl groups caused by oxidative modification produce a new absorbance at 360 nm when derivatized with dinitrophenyl hydrazine (DNPH) (Figure 2A-C) . Thus, the new absorbance characteristics caused by such PTMs as the derivitization of oxidatively modified amino acid residues can be detected at a distinctive absorbance. The data in Figure 2 show a PF2D seconddimensional chromatogram which detects unmodified BSA at 214 nm ( Figure 2A ) and at 360 nm ( Figure 2B , minimal absorbance is detected at 360 nm). On the other hand, the DNP-derivatized carbonylated protein is clearly detected at 360 nm ( Figure 2C ). These data suggest that by derivitization of cell extracts the patterns at 214 nm would produce a global proteome map of the total extract, while the pattern at 360 nm would produce a global proteome map of the derivatized oxidatively damaged proteins. MALDI-TOF mass analyses of the BSA, BSA-DNP, and a BSA/BSA-DNP mixture are shown ( Figure 2D-F) . A mass shift of 180 amu is predicted for every DNP moiety added to a protein. Our unmodified BSA has a mass of 66,431, while the DNP derivatized BSA has a mass of +624 (67,055) indicating that there may be 4 carbonyls that are derivatized with DNPH ( Figure 2E) . A 50/50 mixture of the unmodified BSA and BSA-DNP shows a mass of +387 (66, 668.1) indicating about half of the derived modifications as predicted (Figure 2, panel D vs F) . Although the data indicate that there are ∼4 carbonyls that are derivatized with DNPH, the extra mass, not evenly divisible by 180, suggests that the protein molecules may not be fully oxidized in this in vitro reaction. In addition, the limit of detection of the derivatized BSA is indicated by the dilution series shown in Figure 2G -I, which ranges from 10 µg to 100 ng.
Our experiments have demonstrated that carbonylated proteins can be detected by the PF2D after they are derivatized with 2,4-dinitrophenylhydrazone (DNP) by adjusting the absorbance of the tunable UV wavelength to 360 nm.
Detection of Heme-Containing Proteins, Cytochrome c and Myoglobin. Simultaneous acquisition of signature wavelength scans and a 3D map of cytochrome c is shown in Figure  3 . The data in Figure 3A ,B show the absorbance patterns of cytochrome c (4 µg) at 214 and 395 nm, respectively; the 3D contour map in Figure 3C demonstrates the simultaneous detection of cytochrome c absorbance maxima at 214 nm and ∼400 nm when scanned with the PDA. Similar maps demonstrate the elution pattern of myoglobin (40 µg) at 214 and 395 nm ( Figure 4A,B) and a 3D absorbance pattern produced by scanning the fractions from 190-600 nm ( Figure 4C) .
Detection of Metabolically Modified Proteins: Tyrosine, Serine, Threonine Phosphorylated Proteins. To view phosphorylated proteins, we employed a fluorescence based system that is specific for the HPLC separation and UV detection of phosphopeptides due to their excitation/emission maxima at 555/580 (Molecular Probes, the Pro-Q Diamond LC Phosphopeptide Detection). The system is designed to detect phosphotyrosine, phosphothreonine, and phosphoserine containing peptides based on their slightly altered retention times on the HPLC column. We employed this phosphopeptide detection kit to develop a phosphoprotein proteome map using the PF2D-PDA system. The chromatograms of the standard phosphopeptide, RII, DLDVPIPGRFDRRVPSVAAE, provided by the manufacturer, showed the dual wavelength identification of this peptide when monitored by the PDA detector at 214 and 580 nm during the second-dimensional fractionation ( Figure 5A,B) . We then tested whether the same procedure could detect an intact ProQ derivatized protein. Alpha-casein, a phosphorylated protein, when modified by ProQ treatment, was found to be detectable under the same conditions as the RII control peptide ( Figure 5C,D) .
Application of the same procedure for the detection of phosphorylated protein within a proteome map of a mouse liver tissue extract required certain modifications of the reaction procedure with ProQ. The ProQ phospho-detection reaction requires that the samples be free of salts and buffers. Application of the procedure to a mouse liver extract resulted in some sample precipitation. To address this problem, the protocol was modified by adding the activation and detection reagents first, followed by the addition of membrane lysis buffer. Although this cleared the sample, the precipitation of proteins prior to their ProQ labeling may result in the loss of some proteins and/ or the failure of some proteins to label properly. To address this, we labeled 0.5 mg of mouse liver extract and subjected it to second-dimensional fraction. The data in Figure 6 show that the phosphorylated proteins within a ProQ treated tissue extract can be detected at 214/280 nm during fractionation of a total tissue extract ( Figure 6A,C) ; the phosphoproteins corresponding to peaks detected at 214/280 nm were simultaneously detected at ∼580 nm ( Figure 6B,C) . This multiple detection occurs simultaneously within a scan from 190 to 600 nm. Interestingly, the system also detects other modified proteins at ∼360-430 nm. These signals can correspond to heme-containing proteins, cytochrome P450s, and nitrated proteins. Our system is, therefore, able to detect classes of proteins with unique absorbance outside the main 214/280 nm range. Further applications of this system will include detection assays for the numerous PTMs that foretell oxidative stress and modification, as well as a whole host of disease states. The challenge is to find specific chemistry that targets particular modifications with specific absorbance and is amenable to HPLC. We have shown that nitration, phosphorylation, and carbonylation are possible with this system; however, there is much that can be envisioned to expand the understanding of oxidative stress and the biology of PTMs. For instance, separating phosphotyrosines, phosphothreonines and phosphoserines, and many types of carbonylations from the broad applications shown in this work. Some of these more specific modifications have been dealt with by spotting specific fractions on membranes and probing with specific antibodies or by digesting proteins and identifying the peptides containing modifications with various types of mass spectral analysis.
Detection of Nitrotyrosine-Modified Proteins. It has been reported that nitration of tyrosine residues occurs either as reversible modifications associated with potential signaling functions 18 or irreversible modification due to oxidative damage. 8, 19 Under conditions of acidic pH, nitrated tyrosine residues generate a signature absorbance of the modified protein at 360 nm. 20 To demonstrate the ability of the PF2D-PDA system to simultaneously detect nitrated proteins at 214 and 360 nm, we prepared and fractionated nitrated BSA and lysozyme. The data in Figure 7 show the fractionation of unmodified BSA at 214 nm (A) and at 360 nm (C); a similar fractionation of nitrated BSA shows a slight shift in the absorbance profile of the modified protein detected at 214 nm compared to the unmodified BSA ( Figure 7B ). The nitrated albumin is also detected at 360 nm ( Figure 7D ), and its elution time is at ∼21.5 min. These data suggest that the modification does not significantly alter the absorbance profile of unmodified versus modified albumin. However, the contour maps show that at pH 4.0 the nitrated albumin can be detected as a broad peak which suggests significant change in the protein's properties due to the modification ( Figure 7E,F) . Such changes are likely brought about by the heterogenic nature of the tyrosine residues that are modified. A mass analysis using electrospray ionization on digested nitrated and nonnitrated BSA revealed varying levels of nitration on peptides that contained tyrosine residues (data not shown). When these data were compared to similar analysis by Lee et al. and Petersson et al., 21, 22 it was found that there were many nitrated peptides in common but also some that were unique to the particular study. This may be due in part by the methods employed to modify the protein, the instrumentation used in the analysis, or other unknown factors. The Lee and Petersson studies used tetranitromethane (TNM), while our studies employed peroxynitrite treated BSA which reflects the in vivo type of modifica- tion though not the in vivo levels. The Petersson study reported only 4 out of 21 tyrosines modified and very low levels of a fifth, this despite using the strong nitrating agent TNM. The Lee study reported 16 modified tyrosines but also included peptides that were nitrated and further modified in other ways. Our study revealed 11 modified tyrosines from nitrated BSA and one from BSA that was not modified (data not shown).
Experiments with nitrated lysozyme exhibit the same absorbance patterns at 214 and 360 nm (Figure 8A-D) . As observed with albumin, lysozyme also exhibits a broad peak when nitrated ( Figure 8E,F) .
Detection of Nitrotyrosine-Modified Proteins in Mouse Liver Homogenates. Creatine kinase (CK) is one of the nitrated proteins found in aged mouse quadriceps homogenate. Absorbance signatures of nitrated and non-nitrated CK at 214 nm (a) and from the PDA scan (c) are shown in Figure 9 . Nitrated CK is shown at absorbance 360 nm in panel (c). The offset of 
Discussion
Conventional methods of two-dimensional protein fractionation are time-consuming and laborious to the extent that the fractionated proteome is limited to spot-by-spot analysis. Alternatively, two-dimensional HPLC with UV monitoring allows for fraction archiving, spectral characterization, and rapid Western analysis. We have demonstrated that, in concordance with fractionation, whole proteomes can be characterized as to their carbonylated, nitrated and phosphorylated modifications. We have shown that proteins such as cytochromes with unique spectral signatures can also be identified and quantified. Furthermore, we have utilized a rapid method of Western analysis as applied to whole or defined proteomes. The ability to characterize a proteome is to further understand the global biology of the organism. The significance (and role) of PTMs in the development of physiological characteristics such as embryonic and fetal development, aging, diseases and responses to environmental factors can be achieved rapidly by the systems described here.
Our studies have introduced a spectrophotometric detection system which facilitates the simultaneous detection of proteins with modification-induced changes in absorbance that occur within the range of 190-600 nm. The resultant modifications and applications to this system facilitate the rapid highthroughput construction of multiple proteome maps that include overall protein maps at 214/280 nm and maps of modified proteins ranging from 190 to 600 nm.
In conclusion, we envision the application of this system for the detection and identification of many potential chemical modifications and derivatizations that would facilitate the visualization of PTMs simultaneously, thus, expanding characterization of specific proteomes.
Abbreviations: CF, Anion Exchange Chromatofocusing; 2-DE, two-dimensional gel electrophoresis; PDA, Beckman System Gold 168 Photo Diode Array Detector; PF2D, Beckman Coulter PF2D ProteomeLab; PTM, post-translational modification; RP, reverse phase chromatography. 
